Across the developed world, the sun's long reckoning with human skin is being counted in advance. By 2035, eight major markets will diagnose an estimated 263,000 melanoma cases annually — 34,000 more than today — with the United States carrying the heaviest burden and Australia bearing the highest rate per capita, a consequence of geography, biology, and the unforgiving physics of ultraviolet light. The rise is not sudden but steady, and health systems that read the forecast now may yet build the capacity to meet it with care rather than crisis.
Melanoma cases in major markets projected to surge 15% by 2035
Projected increase of 34,000 additional melanoma cases annually by 2035 across major markets will impact patient populations requiring treatment and care.